• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

MEDTRONIC PLC

Notes

No. Proposition For Against Abstain
1

Election of Director to hold office until the 2026 Annual General Meeting of Medtronic plc (the Company): Craig Arnold

2

Election of Director to hold office until the 2026 Annual General Meeting of Medtronic plc (the Company): Scott C. Donnelly

3

Election of Director to hold office until the 2026 Annual General Meeting of Medtronic plc (the Company): Lidia L. Fonseca

4

Election of Director to hold office until the 2026 Annual General Meeting of Medtronic plc (the Company): John P. Groetelaars

5

Election of Director to hold office until the 2026 Annual General Meeting of Medtronic plc (the Company): Randall J. Hogan, III

6

Election of Director to hold office until the 2026 Annual General Meeting of Medtronic plc (the Company): William R. Jellison

7

Election of Director to hold office until the 2026 Annual General Meeting of Medtronic plc (the Company): Joon S. Lee, M.D.

8

Election of Director to hold office until the 2026 Annual General Meeting of Medtronic plc (the Company): Gregory P. Lewis

9

Election of Director to hold office until the 2026 Annual General Meeting of Medtronic plc (the Company): Kevin E. Lofton

10

Election of Director to hold office until the 2026 Annual General Meeting of Medtronic plc (the Company): Geoffrey S. Martha

11

Election of Director to hold office until the 2026 Annual General Meeting of Medtronic plc (the Company): Elizabeth G. Nabel, M.D.

12

Election of Director to hold office until the 2026 Annual General Meeting of Medtronic plc (the Company): Kendall J. Powell

13

Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Companys independent auditor for fiscal year 2026 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditors remuneration.

14

Approving, on an advisory basis, the Companys executive compensation.

15

Renewing the Board of Directors authority to issue shares under Irish law.

16

Renewing the Board of Directors authority to opt out of pre-emption rights under Irish law.

17

Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.

18

Approving an amendment to Article 177 of the Companys Articles of Association, to facilitate the capitalization of certain of the Companys non-distributable reserves.

19

Approving a Capital Reduction to Create Distributable Reserves under Irish Law.

20

Approving amendments to the Companys Articles of Association, to update the advance notice provisions.